Alliance Family Dental, Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: 916 W 10th St, Alliance, NE 69301 Phone: 308-762-6131 Fax: 308-762-6132 |
Alliance Dental Clinic Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2308 Box Butte Ave., Alliance, NE 69301 Phone: 308-762-6354 |
Brandon R. Wilcox, D.d.s., P.c. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 916 W 10th St, Alliance, NE 69301 Phone: 308-762-6131 Fax: 308-762-6132 |
News Archive
Researchers from The University of Adelaide in South Australia found that a specific peptide in the spider venom could be used to understand how people sense pain.
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that Jessica Castle, M.D., an associate professor of medicine in the OHSU School of Medicine and OHSU Harold Schnitzer Diabetes Health Center in Portland, Oregon, is conducting a clinical trial with a dual-hormone artificial pancreas using Xeris' ready-to-use liquid glucagon to evaluate a new closed-loop algorithm.
University of Minnesota researchers contributed to a national effort to sequence the genome of an ancient, one-celled organism that will help advance research in a broad range of areas, from biofuels to restoring the environment to understanding a variety of human diseases.
The New York Times: "Republicans captured control of the House of Representatives on Tuesday and expanded their voice in the Senate, riding a wave of voter discontent as they dealt a setback to President Obama just two years after his triumphal victory. A Republican resurgence, propelled by deep economic worries and a forceful opposition to the Democratic agenda of health care and government spending, delivered defeats to House Democrats from the Northeast to the South and across the Midwest" (Zeleny, 11/2).
Researchers at Mount Sinai School of Medicine have developed a new gene therapy that is safe and effective in reversing advanced heart failure. SERCA2a (produced as MYDICAR-) is a gene therapy designed to stimulate production of an enzyme that enables the failing heart to pump more effectively.
› Verified 9 days ago